S-Equol mitigates motivational deficits and dysregulation associated with HIV-1
Abstract Motivational deficits (e.g., apathy) and dysregulation (e.g., addiction) in HIV-1 seropositive individuals, despite treatment with combination antiretroviral therapy, necessitates the development of innovative adjunctive therapeutics. S-Equol (SE), a selective estrogen receptor β agonist, h...
Enregistré dans:
Auteurs principaux: | Kristen A. McLaurin, Sarah J. Bertrand, Jessica M. Illenberger, Steven B. Harrod, Charles F. Mactutus, Rosemarie M. Booze |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e54c76ad5c684d5f8c80d1bf6cbe203a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Neurodevelopmental Processes in the Prefrontal Cortex Derailed by Chronic HIV-1 Viral Protein Exposure
par: Kristen A. McLaurin, et autres
Publié: (2021) -
Association between Equol Production Status and Nonalcoholic Steatohepatitis
par: Takemi Akahane, et autres
Publié: (2021) -
Urinary equol levels are positively associated with urinary estradiol excretion in women
par: Tomoko Fujitani, et autres
Publié: (2021) -
Motivating actions to mitigate plastic pollution
par: Lili Jia, et autres
Publié: (2019) -
Potential Protective Effects of Equol (Soy Isoflavone Metabolite) on Coronary Heart Diseases—From Molecular Mechanisms to Studies in Humans
par: Xiao Zhang, et autres
Publié: (2021)